Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbott, Bostongene, Caresyntax, Curonix, Cytek, Gimmi , Onward Medical, Novocure, Orthofix Medical, Painteq, Rescale, Sure Med, Total Scope, MC Healthcare, Vysioneer.

Additional early-stage research and drug discovery news in brief, from: Poolbeg Pharma, Vast Therapeutics.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: ERS, Invo, Lee’s, Medac, Naya, Stemsight, Urogen, Windtree.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Karkinos, Mediforum, Personalis, Sensydia, Sophia Genetics, Vision Sensing.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Affluent Medical, Biomage, Blackford, Bot Image, Canon Medical, Complete Genomics, Concentric, Gencove, Dignitana, Ginkgo Bioworks, Icecure, Illumina, Lifecore, Lumithera, Lunit, Oncomedical, Olympus, Parse Biosciences, Samsung Electronics, W.L. Gore.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Accurus, Basilea, Bausch + Lomb, Biosenic, Compass, Coya, Deka, Dewpoint, Emergex, Epilepsy, Epivario, Eyenovia, Genevant, Immpact, Intravacc, Medsenic, Metabomed, Phebra, Spexis, Substipharm, Therapeutic Solutions, Tome, Transcode, Veritascience, Zuellig.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Biontech, Enamine, Henlius, Sermonix, Syntheticgestalt, Wuxi.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ampio, Arena Bioworks, Biontech, Debiopharm, Elevatebio, Emergent, Enamine, Henlius, Immunitybio, Ladrx, Sermonix, Syntheticgestalt, Thinkingnode, Wuxi Bio, Xcell, Xoma, Zevra.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Clinchoice, CSI Medical, Extremity Medical, Henry Schein.

Additional early-stage research and drug discovery news in brief, from: Resverlogix.